Biosensis is a company that is passionate about Science. Formed in 2006 by a team of life scientists and business people, Biosensis is dedicated to the support of researchers in academia and industry worldwide. The management team has a combined total of over 100 years of experience in basic and applied life science research and over 70 years in the commercialization of life science antibodies, reagents, and kits for the life science research and diagnostic markets. We therefore intimately understand the need for researchers to have quality reagents that work. With a combined total of 400+ peer-reviewed research publications and superb technical support and experience, Biosensis is able to offer a level of customer support and scientific expertise unmatched in the industry for Neuroscience and its related research fields.
Our Vision is to become a Life Science company supporting researchers in their quest for prevention, diagnosis and treatment of human diseases. Our mission is to provide relevant information, innovative validated products in easy-to-use formats, and technical know-how. Our goals are supportive of our vision and mission. We aim to:
Biosensis specializes in ELISA kits, antibodies, proteins and staining reagents for Neuroscience, with particular emphasis on neurotrophins and neurotrophin receptors, for which Biosensis has been the worldwide leader and OEM supplier for nearly 30 years. Our neuroscience portfolio includes products for research in neurodegenerative diseases, neurodevelopment, and neuro-metabolism. Areas of focus include Alzheimer's, Parkinson's and ALS diseases, as well as autophagy and metabolic and stress disorders including metabolic syndrome research, obesity, and neuroimmunology and inflammation. Highlights from our unique product range include: BDNF and NGF isoform-specific Rapid™ ELISA kits, NGFR/p75ECD biomarker Rapid™ ELISA kit, Oligomeric Amyloid-beta ELISA kit, Amylo-Glo amyloid plaque staining reagent, Fluoro-Jade B and C tracing reagents.
GroPep Bioreagents (www.gropep.com) was acquired in October 2020 and is now a member of the Biosensis family. GroPep Bioreagents has developed and manufactured growth factors, antibodies and associated protein reagents for researchers in universities, research institutes, biotechnology and pharmaceutical companies since 1990. Accredited to ISO9001:2016 to allow incorporation into diagnostics, lead products include human LR3 IGF-I, IGF-I, IGF-II and IGF-BP3 proteins.
Biosensis is a continuous exhibitor at the annual Society for Neuroscience (SFN) meeting held in the USA and attends other conferences throughout the year. The Biosensis booth is managed by Ms Carol Birmingham, MBA and Dr. Lyndon M Foster, MS, Ph.D. Carol has over 40 years experience in the life science industry. Her positions include Senior Product Manager at Chemicon (now part of Millipore-Sigma) and marketing and new product development at PhosphoSolutions. Lyndon has over 30 years experience in the life science industry and his previous positions include Chief Technical Officer for Chemicon and Senior Director for worldwide technical services for Serologicals/Millipore.